BCL2-BH4 antagonist BDA-366 suppresses human myeloma growth.
about
Smac mimetic LCL161 overcomes protective ER stress induced by obatoclax, synergistically causing cell death in multiple myeloma.Non-canonical roles of Bcl-2 and Bcl-xL proteins: relevance of BH4 domain.Modulation of Ca2+ Signaling by Anti-apoptotic B-Cell Lymphoma 2 Proteins at the Endoplasmic Reticulum-Mitochondrial Interface.Targeting signaling and apoptotic pathways involved in chemotherapeutic drug-resistance of hematopoietic cells.TAT‑fused IP3R‑derived peptide enhances cisplatin sensitivity of ovarian cancer cells by increasing ER Ca2+ release.
P2860
BCL2-BH4 antagonist BDA-366 suppresses human myeloma growth.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 March 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
BCL2-BH4 antagonist BDA-366 suppresses human myeloma growth.
@en
BCL2-BH4 antagonist BDA-366 suppresses human myeloma growth.
@nl
type
label
BCL2-BH4 antagonist BDA-366 suppresses human myeloma growth.
@en
BCL2-BH4 antagonist BDA-366 suppresses human myeloma growth.
@nl
prefLabel
BCL2-BH4 antagonist BDA-366 suppresses human myeloma growth.
@en
BCL2-BH4 antagonist BDA-366 suppresses human myeloma growth.
@nl
P2093
P2860
P356
P1433
P1476
BCL2-BH4 antagonist BDA-366 suppresses human myeloma growth.
@en
P2093
Ajay Nooka
Dongkyoo Park
Jacques Galipeau
Jiusheng Deng
Jonathan Kaufman
Lawrence H Boise
Mengchang Wang
Qiaoya Deng
Shannon Matulis
Xingming Deng
P2860
P304
27753-27763
P356
10.18632/ONCOTARGET.8513
P407
P50
P577
2016-03-31T00:00:00Z